-
-
-
-
-
-
-
ImmuCell Announces a 28.4% Increase in Product Sales in Q1 of 2026, based on Preliminary, Unaudited Sales Results
-
-
-
-
-
-
-
ImmuCell pauses Re-Tain development after FDA rejection, shifts to First Defense
-
-
-
-
-
-
-
ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 of 2025
-
-
-
-
-
-
-
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2025
-
-
-
-
-
-
-
ImmuCell Announces Preliminary, Unaudited Sales ResultsĀ for Q1 of 2025
-
-
-
-
-
-
-
Immucell Corp (ICCC) Announces Settlement of Insurance Claim Related to Previously Disclosed Production Contamination Losses
-
-
-
-
-
-
-
ImmuCell Announces Preliminary, Unaudited Sales ResultsĀ for Q3 2024
-
1,203,949 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

